Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Suramin - Rediscovery Life Sciences

Next Previous
Drug Profile

Suramin - Rediscovery Life Sciences

Alternative Names: RLS 003

Latest Information Update: 31 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rediscovery Life Sciences
  • Class Antiprotozoals; Behavioural disorder therapies; Benzamides; Naphthalenesulfonates
  • Mechanism of Action Epidermal growth factor inhibitors; Insulin-like growth factor I inhibitors; Platelet-derived growth factor inhibitors; RNA-directed DNA polymerase inhibitors; Transforming growth factor beta inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acute kidney injury

Most Recent Events

  • 13 Nov 2020 Phase-II clinical trials in Acute kidney injury in USA (IV) (NCT04496596)
  • 11 Aug 2020 Rediscovery Life Sciences has a patent protection for RLS 003 (Rediscovery Life Sciences, website, August 2020)
  • 03 Aug 2020 Rediscovery Life Sciences plans a phase II trial for Acute kidney injury (AKI) in USA in September 2020 (NCT04496596)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top